Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 346321 - 346340 out of 485545 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib SUN, tabl. powl., 50 mg | 60 szt., 50 mg , 60 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | SunPharmaceuticalIndustriesEuropeB.V. |
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib Viatris, tabl. powl., 50 mg | 60 szt., 50 mg , 60 tabl. w blistrze | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | ViatrisLtd |
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib Zentiva, tabl. powl., 50 mg | 60 szt., 50 mg , 60 tabl. w blistrze | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EA02) dasatinib (adm: O) | Daruph, tabl. powl., 63 mg | 30 szt., 63 mg , 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EA02) dasatinib (adm: O) | Daruph, tabl. powl., 79 mg | 30 szt., 79 mg , 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib Sandoz, tabl. powl., 80 mg | 30 szt., 80 mg , 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | SandozGmbH |
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib Stada, tabl. powl., 80 mg | 30 szt., 80 mg , 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | STADAArzneimittelAG |
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib SUN, tabl. powl., 80 mg | 30 szt., 80 mg , 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | SunPharmaceuticalIndustriesEuropeB.V. |
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib Viatris, tabl. powl., 80 mg | 30 szt., 80 mg , 30 tabl. w blistrze | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | ViatrisLtd |
| Poland | (L01EA02) dasatinib (adm: O) | Dasatinib Zentiva, tabl. powl., 80 mg | 30 szt., 80 mg , 30 tabl. w blistrze | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EA03) nilotinib (adm: O) | Tasigna, kaps. twarde, 200 mg | 112 szt., 200 mg , 112 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited |
| Poland | (L01EA04) bosutinib (adm: O) | Bosutinib Stada, tabl. powl., 100 mg | 28 szt., 100 mg , 28 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | STADAArzneimittelAG |
| Poland | (L01EA04) bosutinib (adm: O) | Bosutinib Stada, tabl. powl., 500 mg | 28 szt., 500 mg , 28 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | STADAArzneimittelAG |
| Poland | (L01EA04) bosutinib (adm: O) | Bosutinib Zentiva, tabl. powl., 100 mg | 28 szt., 100 mg , 28 tabl. w blistrze | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EA04) bosutinib (adm: O) | Bosutinib Zentiva, tabl. powl., 500 mg | 28 szt., 500 mg , 28 tabl. w blistrze | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EA04) bosutinib (adm: O) | Bosulif, tabl. powl., 100 mg | 28 szt., 100 mg , 28 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | PfizerEuropeMAEEIG |
| Poland | (L01EA04) bosutinib (adm: O) | Bosulif, tabl. powl., 500 mg | 28 szt., 500 mg , 28 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | PfizerEuropeMAEEIG |
| Poland | (L01EA05) ponatinib (adm: O) | Iclusig, tabl. powl., 15 mg | 60 szt., 15 mg , 60 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | IncyteBiosciencesDistributionB.V. |
| Poland | (L01EA05) ponatinib (adm: O) | Iclusig, tabl. powl., 45 mg | 30 szt., 45 mg , 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | IncyteBiosciencesDistributionB.V. |
| Poland | (L01EA06) asciminib (adm: O) | Scemblix, tabl. powl., 20 mg | 60 szt., 20 mg , 60 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited |
Pages
